This morning the Federal Circuit released five nonprecedential orders dismissing appeals. Here are links to the dismissals.
- Big Pharma to Face Off at Federal Circuit Oral Arguments Over Antibody Genus Patentability – A preview of an upcoming Federal Circuit case concerning enablement.
- No Patent? No Problem! The Federal Circuit Paves The Way For Non-Patent Owners To Sue Infringers – What happens in a patent lawsuit when not all of the parties that have an ownership interest in a patent are joined as plaintiffs?
- The Federal Circuit Tries To Demystify Venue in Hatch-Waxman Actions – In Valeant Pharms. N. Am. v. Mylan Pharms., the Federal Circuit attempted to clarify where “acts of infringement” for venue purposes under §1400(b) occur in Hatch-Waxman actions.
Here’s the latest.
This morning the Federal Circuit issued two precedential opinions in patent cases, four nonprecedential opinions in patent cases, and one nonprecedential order in a patent case dismissing an appeal as moot. Here are the introductions to the opinions and text from the order.